Stock PCRX PACIRA BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Governance Pacira BioSciences, Inc.

Equities

PCRX

US6951271005

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-09-19 pm EDT 		5-day change 1st Jan Change
14.69 USD +0.27% Intraday chart for Pacira BioSciences, Inc. +15.40% -56.46%
Sep. 09 Pacira Biosciences, Inc. Announces Board Changes CI
Aug. 13 Truist Securities Downgrades Pacira BioSciences to Sell From Buy, Adjusts Price Target to $8 From $30 MT

Executive Committee: Pacira BioSciences, Inc.

Manager
Positions heldSince
Frank Lee

Frank Lee

56 year

Chief Executive Officer 2024-01-01
Anthony Molloy

Anthony Molloy

50 year

Compliance Officer -
General Counsel -
Daryl Gaugler

Daryl Gaugler

62 year

Chief Operating Officer 2022-05-03
Jonathan Slonin

Jonathan Slonin

49 year

Chief Tech/Sci/R&D Officer 2021-06-30
Susan Mesco

Susan Mesco

Investor Relations Contact 2015-03-31
Charles Reinhart

Charles Reinhart

63 year

Director of Finance/CFO 2016-04-30
Kristen Williams

Kristen Williams

50 year

Chief Administrative Officer 2014-09-30
General Counsel 2011-11-30
Corporate Secretary 2014-09-30

Composition of the Board of Directors: Pacira BioSciences, Inc.

Director
CommitteesSince
Paul Hastings

Paul Hastings

64 year

Compensation Committee 2024-01-01
Governance Committee 2024-01-01
Nominating Committee 2024-01-01
Laura Brege

Laura Brege

66 year

Governance Committee 2019-07-16
Nominating Committee 2019-07-16
Audit Committee Chair 2011-05-31
Compensation Committee 2020-11-30
Mark Kronenfeld

Mark Kronenfeld

69 year

Compensation Committee 2013-09-12
Governance Committee Chair 2013-06-11
Nominating Committee Chair 2013-06-11
Alethia Young

Alethia Young

45 year

Audit Committee 2023-10-09
Governance Committee 2022-06-08
Nominating Committee 2022-06-08
Andreas Wicki

Andreas Wicki

64 year

Audit Committee
Compensation Committee
Mark Froimson

Mark Froimson

63 year

Audit Committee 2017-06-14
Abraham Ceesay

Abraham Ceesay

46 year

Compensation Committee 2023-10-09
Michael Yang

Michael Yang

62 year

Compensation Committee Chair 2023-10-09
Frank Lee

Frank Lee

56 year

Director/Board Member 2024-01-01
Marcelo Bigal

Marcelo Bigal

54 year

Director/Board Member 2023-10-09
Independent Dir/Board Member 2023-10-09
Christopher Christie

Christopher Christie

61 year

Director/Board Member 2019-09-17
Independent Dir/Board Member 2019-09-17

Latest Appointments: Pacira BioSciences, Inc.

Pacira Biosciences, Inc. Announces Board Changes CI
Pacira BioSciences, Inc. Announces Departure of Charles A. Reinhart, III, as Chief Financial Officer, Effective September 30, 2024 CI
Pacira BioSciences, Inc. Appoints Frank D. Lee as Chief Executive Officer, Effective January 2, 2024 CI
Pacira Biosciences, Inc. Appoints Frank D. Lee as Member of the Board, Effective January 2, 2024 CI
Pacira BioSciences Names Frank D. Lee CEO, Board Member MT
Pacira Biosciences Appoints Four New Independent Directors to Its Board of Directors CI
Pacira BioSciences Chief Executive to Retire MT
More news

Former Officers and Directors: Pacira BioSciences, Inc.

Insider
Positions held
SinceUntil
Gary Pace
Gary Pace
Director/Board Member 2008-05-31 2024-06-29
Independent Dir/Board Member 2008-05-31 2024-06-29
David Stack
David Stack
Director/Board Member 2010-11-02 2013-07-11
Chief Executive Officer 2007-10-31 2023-12-31
Chairman 2013-07-11 2023-12-31
Chief Operating Officer 2018-03-26 2022-05-03
President 2007-10-31 2015-10-19
Richard Kahr
Richard Kahr
Human Resources Officer 2015-01-31 2023-11-30
Charles Laranjeira
Charles Laranjeira
Chief Tech/Sci/R&D Officer 2017-04-30 2023-05-31
Yvonne Greenstreet
Yvonne Greenstreet
Director/Board Member 2014-03-03 2023-03-30
Independent Dir/Board Member 2014-03-03 2023-03-30
Donald C. Manning
Donald C. Manning
Chief Tech/Sci/R&D Officer 2020-05-03 2021-06-15
Vladimir Kharitonov
Vladimir Kharitonov
Chief Tech/Sci/R&D Officer 2012-05-23 2020-07-31
Corporate Officer/Principal 2010-11-02 2012-05-23
Richard Scranton
Richard Scranton
Chief Tech/Sci/R&D Officer 2017-05-31 2020-01-23
Corporate Officer/Principal - 2017-12-06
Max Reinhardt
Max Reinhardt
Corporate Officer/Principal 2020-06-08 -
President 2019-06-18 2020-06-08
Dennis L. Winger
Dennis L. Winger
Director/Board Member 2013-09-10 2018-06-11
Independent Dir/Board Member 2013-09-10 2018-06-11
Scott Braunstein
Scott Braunstein
Chief Operating Officer 2017-12-10 2018-03-26
Corporate Officer/Principal 2015-07-13 2017-12-10
James Scibetta
James Scibetta
Director of Finance/CFO 2008-07-31 2016-05-02
President 2015-10-19 2017-06-29
Thomas Sluby
Thomas Sluby
Sales & Marketing 2016-10-19 2016-12-31
Harry Kovelman
Harry Kovelman
Chief Tech/Sci/R&D Officer 2013-12-31 2016-12-31
Roy Winston
Roy Winston
Chief Tech/Sci/R&D Officer 2018-07-31 -
Corporate Officer/Principal 2016-12-31 2018-07-31
Sergio Alegre
Sergio Alegre
Director/Board Member 2012-07-31 2016-07-31
Robert J. Weiland
Robert J. Weiland
Corporate Officer/Principal 2016-03-31 -
Taunia S. Markvicka
Taunia S. Markvicka
Corporate Officer/Principal 2007-12-31 2016-01-06
Vinay Shah
Vinay Shah
Corporate Officer/Principal 2007-12-31 2015-12-31
Gary Patou
Gary Patou
Chief Tech/Sci/R&D Officer 2010-11-02 2015-08-18
James B. Jones
James B. Jones
Chief Tech/Sci/R&D Officer 2015-08-16 -
Dennis Mcloughlin
Dennis Mcloughlin
Corporate Officer/Principal 2018-07-31 -
Luke Evnin
Luke Evnin
Director/Board Member 2006-11-30 2013-09-29
Independent Dir/Board Member 2011-05-25 2013-09-29
Fred Middleton
Fred Middleton
Director/Board Member 2013-07-11 2013-09-29
Tim M. Ciaccio
Tim M. Ciaccio
Chief Tech/Sci/R&D Officer 2012-07-31 -
Paul R. Ellwood
Paul R. Ellwood
Human Resources Officer 2012-04-30 -
Mark Walters
Mark Walters
Chief Tech/Sci/R&D Officer 2011-12-26 2011-12-31
Corporate Officer/Principal 2009-10-20 2011-12-26
William J. Lambert
William J. Lambert
Corporate Officer/Principal 2010-11-02 2011-09-29
Carl Gordon
Carl Gordon
Director/Board Member 2009-10-20 2011-06-02
Independent Dir/Board Member 2011-05-25 2011-06-02
David St. Peter
David St. Peter
Corporate Officer/Principal 2008-09-30 2009-05-31
Fred M. Ryan
Fred M. Ryan
Corporate Officer/Principal 2009-10-20 -
John P. Longenecker
John P. Longenecker
Director/Board Member 2007-06-30 -
Independent Dir/Board Member 2007-06-30 -
Lynette M. Bowman
Lynette M. Bowman
Human Resources Officer 2010-11-02 -
Admir Hadzic
Admir Hadzic
Corporate Officer/Principal - -
Doug Silveira
Doug Silveira
Corporate Officer/Principal - -
David Kaplan
David Kaplan
Sales & Marketing - -
Jessica Cho
Jessica Cho
Investor Relations Contact - -
Ronald M. Burch
Ronald M. Burch
Chief Tech/Sci/R&D Officer 2009-10-20 -
Ron Ellis
Ron Ellis
Corporate Officer/Principal - -

Age distribution of managers

Parity Men Women

Male 14
Female 6

Of which Executive Committee

Male 5
Female 2

Of which Directors

Male 9
Female 2
ESG Refinitiv
B-

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Company Profile

Logo Pacira BioSciences, Inc.
Pacira BioSciences, Inc. is a holding company for Pacira Pharmaceuticals, Inc. The Company's non-opioid treatments include EXPAREL (bupivacaine liposome injectable suspension), which is a long-acting, local analgesic for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), which is an extended-release, intra-articular (IA), corticosteroid injection indicated for OA knee pain, and Iovera, which is a novel handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. EXPAREL is used across multiple orthopedic procedures, including joint reconstruction, shoulder, spine, extremity procedures, and hip fractures. It is developing interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain. Its clinical development programs include PCRX-201, and pMVL-Based Clinical Program.
Employees
712
Sector
Pharmaceuticals
Calendar
2024-10-30 - Q3 2024 Earnings Release (Projected)
More about the company

Departures of Key Persons

David Stack
-
David Stack

Chief Executive Officer

2007-10-31 2023-12-31

  1. Stock Market
  2. Equities
  3. PCRX Stock
  4. Company Pacira BioSciences, Inc.
  5. Governance